From his baronial boardroom in Pune, Adar Poonawalla can appear out upon the properly manicured turf of India’s most significant stud farm. Over the years, the family’s racehorses have received the Indian Derby 10 periods. These days, however, the thoroughbreds gambolling throughout the paddock beneath his window may perhaps be the past matter on his thoughts.
As the earth gears up for a race to vaccinate billions of men and women towards Covid-19, the forty-calendar year-outdated scion of India’s Poonawalla pharmaceuticals dynasty has emerged as a key player. As main govt of Serum Institute of India (SII), the world’s most significant vaccine manufacturer by quantity, Poonawalla’s manufacturing unit 70 miles outside Mumbai has been working at entire tilt, scrambling to make 50m doses for each thirty day period of the AstraZeneca/College of Oxford vaccine which it is hoped will assistance bring the killer virus beneath management.
Indicators of the pressures